MACROBID Drug Patent Profile
✉ Email this page to a colleague
When do Macrobid patents expire, and what generic alternatives are available?
Macrobid is a drug marketed by Almatica and is included in one NDA.
The generic ingredient in MACROBID is nitrofurantoin; nitrofurantoin, macrocrystalline. There are twenty drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the nitrofurantoin; nitrofurantoin, macrocrystalline profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MACROBID?
- What are the global sales for MACROBID?
- What is Average Wholesale Price for MACROBID?
Summary for MACROBID
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 11 |
Raw Ingredient (Bulk) Api Vendors: | 85 |
Clinical Trials: | 13 |
Drug Prices: | Drug price information for MACROBID |
What excipients (inactive ingredients) are in MACROBID? | MACROBID excipients list |
DailyMed Link: | MACROBID at DailyMed |
Recent Clinical Trials for MACROBID
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Albert Einstein Healthcare Network | Phase 4 |
Baylor Research Institute | Phase 4 |
National Cancer Institute (NCI) | Phase 4 |
Pharmacology for MACROBID
Drug Class | Nitrofuran Antibacterial |
US Patents and Regulatory Information for MACROBID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Almatica | MACROBID | nitrofurantoin; nitrofurantoin, macrocrystalline | CAPSULE;ORAL | 020064-001 | Dec 24, 1991 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MACROBID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Almatica | MACROBID | nitrofurantoin; nitrofurantoin, macrocrystalline | CAPSULE;ORAL | 020064-001 | Dec 24, 1991 | ⤷ Sign Up | ⤷ Sign Up |
Almatica | MACROBID | nitrofurantoin; nitrofurantoin, macrocrystalline | CAPSULE;ORAL | 020064-001 | Dec 24, 1991 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for MACROBID
See the table below for patents covering MACROBID around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | S63258407 | SLOW RELEASE CAPSULE | ⤷ Sign Up |
Australia | 7421287 | ⤷ Sign Up | |
Ireland | 871585 | ⤷ Sign Up | |
Israel | 82807 | NITROFURANTOIN DOSAGE FORM | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |